What is the fine-grained topic of the following text: LONDON, ONTARIO and BOSTON, MASSACHUSETTS--(Marketwired - Sept. 5, 2017) - Critical Outcome Technologies Inc. (TSX VENTURE:COT)(OTCQB:COTQF) ("COTI" or the "Company"), a clinical stage biopharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, today announced that Dr. Richard Ho, Chief Scientific Officer, will present at the Rodman & Renshaw 19th Annual Global Investment Conference on Tuesday, September 12, 2017 at 3:50 P.M. Only return the topic.
Dr. Richard Ho's presentation at the Rodman & Renshaw 19th Annual Global Investment Conference.